INTERNATIONAL PATENT: ADVERUM BIOTECHNOLOGIES, INC. FILES APPLICATION FOR "METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT"

GENEVA, Jan. 27 -- ADVERUM BIOTECHNOLOGIES, INC. (100 Cardinal WayRedwood City, California 94063) filed a patent application (PCT/US2025/037856) for "METHODS OF TREATING OCULAR NEOVASCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT" on Jul 16, 2025. With publication no. WO/2026/019885, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TURPCU, Adam (c/o Adverum Biotechnologies, Inc.100 Cardinal WayRedwood City, California 94063)

Abstract: Provided are methods for treating an ocular neovascular disease in an individua...